• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC THERMOCOOL® SMART TOUCH® SF BI-DIRECTIONAL NAVIGATION CATHETER; CARDIAC ABLATION PERCUTANEOUS CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC THERMOCOOL® SMART TOUCH® SF BI-DIRECTIONAL NAVIGATION CATHETER; CARDIAC ABLATION PERCUTANEOUS CATHETER Back to Search Results
Model Number D134801
Device Problem Patient Device Interaction Problem (4001)
Patient Problems Fistula (1862); Paralysis (1997); Cardiac Tamponade (2226)
Event Date 09/23/2022
Event Type  Injury  
Event Description
This complaint is from a literature source.The following literature cite has been reviewed: heinroth k, blum t, drexler m, plehn a, hartkopf t, horenburg c, sedding d.X-ray exposure in cryoballoon versus radiofrequency ablation for atrial fibrillation over 7 years: a single center study.J arrhythm.2022 sep 23;38(6):1017-1027.Doi: 10.1002/joa3.12780.Pmid: 36524039; pmcid: pmc9745457.Abstract: background: facing an increasing number of radiofrequency ablation (rf) and cryoballoon ablation (cb) procedures for treatment of af radiation exposure and its reduction is a focus point for interventional electrophysiologists.Objective: this study evaluated the procedural parameters of the different ablation methods focusing on radiation exposure and the bmi of the patients.Methods: one thousand one hundred and thirty-three first procedural cases of pulmonary vein isolation in patients with paroxysmal and persistent af treated with rf and cb-based techniques were analyzed retrospectively over a period of 7 years focusing on the endpoints dose area product (dap, cgycm2 ), fluoroscopy time (ft, min) and procedural time (pt, min).Results: of the 1133 patients (mean age 63.4 ±11.4 years, bmi 28.9 ±4.7) 335 patients received an rf procedure, 211 patients were treated with the cryoballoon first generation (cb1), and 587 patients with cryoballoon second generation (cb2), respectively.The mean dap for the pvi was 508±654 cgycm2 in rf procedures, 1077±683 cgycm2 in cb1-procedures, and 587±489 cgycm2 in cb2-procedures with fluoroscopy times significantly shorter in rf procedures (9.6 ±5.2 min) as compared to 17.7 ±5.9 min in cb1- and 16.3 ±6.3 min in cb2-procedures (p <.001).At the same time, the procedure duration using rf (115±33.5 min) was significantly longer than both in cb1 (96±16.8 min) and cb2 procedures (75±15.9 min).Conclusions: despite longer fluoroscopy durations in the cb technique, the cb2 resulted in a comparable low radiation exposure in pvi as compared to rf, accompanied by shorter procedure durations.Lot, model and catalog number are not available, but the suspected biosense webster device possibly associated with reported adverse events: thermocool smarttouch other biosense webster devices that were also used in this study: carto 3, lasso mapping catheter non-biosense webster devices that were also used in this study for rf ablation: 6 f quadripolar steerable catheter (dynamic xt®, boston scientific), 5-f quadripolar catheter (cournand-curve, supreme®, st.Jude medical).Non-biosense webster devices that were also used in this study for cryoballoon ablation was performed with a steerable 6 f quadripolar catheter (dynamic xt®, boston scientific); 6-f quadripolar catheter (cournand-curve, supreme®, st.Jude medical); e sheath-dilator-complex (fast cath® sl0, 63cm, and brk1-needle®, 71cm: st.Jude medical); 12-f-flexcath® or flexcath advance® sheath (medtronic); 10-polar achieve® (medtronic); cryoballoon (28mm diameter) arctic front® (cb1) or arctic front advance® (cb2).Adverse event(s) and provided interventions for the rf ablation group: qty 10 pericardial tamponade (interventions not discussed in article) qty 2 phrenic nerve palsy (all phrenic nerve palsies disappeared within 12 months; interventions not discussed in article).Qty 2 ateriovenous fistula (interventions not discussed in article and no reported deaths).
 
Manufacturer Narrative
This complaint is from a literature source.The following literature cite has been reviewed: heinroth k, blum t, drexler m, plehn a, hartkopf t, horenburg c, sedding d.X-ray exposure in cryoballoon versus radiofrequency ablation for atrial fibrillation over 7 years: a single center study.J arrhythm.2022 sep 23;38(6):1017-1027.Doi: 10.1002/joa3.12780.Pmid: 36524039; pmcid: pmc9745457.No device was received for analysis at the time of submission of the initial 3500a.Since the product was not returned for analysis, no product failure analysis can be conducted, and no determination of possible contributing factors could be made.Device history record (dhr) review cannot be conducted because no lot number was provided by the customer.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's ref # (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERMOCOOL® SMART TOUCH® SF BI-DIRECTIONAL NAVIGATION CATHETER
Type of Device
CARDIAC ABLATION PERCUTANEOUS CATHETER
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER INC (JUAREZ)
circuito interior norte
1820parque industrial salvacar
juarez 32599
MX   32599
Manufacturer Contact
kate karberg
31 technology dr
irvine, CA 92618
3035526892
MDR Report Key16440247
MDR Text Key310231431
Report Number2029046-2023-00386
Device Sequence Number1
Product Code LPB
UDI-Device Identifier10846835010145
UDI-Public10846835010145
Combination Product (y/n)N
Reporter Country CodeGM
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 02/24/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/24/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberD134801
Device Catalogue NumberUNK_SMART TOUCH BIDIRECTIONAL
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/30/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
5-F QUADRIPOLAR CATHETER (COURNAND-CURVE, SUPREME.; 6F QUADRIPOLAR STEERABLE CATHETER DYNAMIC XT.; UNK_CARTO 3.; UNK_LASSO.
Patient Outcome(s) Life Threatening;
-
-